| Sep'18 | May'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||
Net income | ||||||
12,190 | 8,587 | -1,851 | -3,126 | -31 | 299 | -5 |
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||
Change in fair value of deferred underwriting fee liability | ||||||
- | - | 4 | -66 | -91 | 167 | 0 |
Unrealized loss on marketable securities held in Trust Account | ||||||
- | - | -29 | 7 | -38 | 28 | 0 |
Interest earned on marketable securities held in Trust Account | ||||||
- | - | 733 | 589 | 570 | 179 | 0 |
Changes in operating assets and liabilities: | ||||||
(Increase) in prepaid expenses | ||||||
- | - | 24 | -27 | -23 | 178 | 0 |
Accrued expenses | ||||||
- | - | 1,963 | 3,147 | 286 | 39 | 0 |
Net cash provided by operating activities | ||||||
- | - | -620 | - | - | - | -5 |
Cash Flows from Financing Activities: | ||||||
Proceeds from advance from related party | ||||||
- | - | 0 | 60 | 42 | 167 | -78 |
Proceeds from promissory note related parties | ||||||
- | - | 0 | 0 | 0 | 161 | 137 |
Redemption of ordinary shares | ||||||
- | - | 0 | 0 | 0 | 508 | 206 |
Proceeds from issuance of shares | ||||||
- | - | 0 | 0 | 0 | 0 | 25 |
Net cash provided by (used in) financing activities | ||||||
- | - | 0 | - | - | - | 34 |
Net increase in cash | ||||||
- | - | -620 | -503 | -149 | 1,365 | 28 |
Supplemental disclosure of cash flow information | ||||||
Change in value of ordinary shares subject to possible redemption | ||||||
- | - | 519 | 440 | 393 | 153 | 0 |